Presentations

Investor Contact

Stern Investor Relations
Hannah Deresiewicz
+1-212-362-1200
Hannah.Deresiewicz@sternir.com

Date	Title
05/21/20	Kala Pharmaceuticals Corporate Overview May 2020 1.9 MB